These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2679719)

  • 21. [Allergen-specific immunotherapy--vaccination against allergy].
    Brygge T; Mosbech H
    Ugeskr Laeger; 2000 Jan; 162(4):524-7. PubMed ID: 10697458
    [No Abstract]   [Full Text] [Related]  

  • 22. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 23. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment?
    Epstein TE; Tankersley MS
    J Allergy Clin Immunol Pract; 2017; 5(5):1227-1233. PubMed ID: 28709818
    [No Abstract]   [Full Text] [Related]  

  • 25. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
    Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M
    J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341
    [No Abstract]   [Full Text] [Related]  

  • 26. Broad perspectives of allergen specific immunotherapy.
    Thomas WR
    Hum Vaccin Immunother; 2017 Oct; 13(10):2385-2389. PubMed ID: 28933669
    [No Abstract]   [Full Text] [Related]  

  • 27. Does clinical protection persist after food allergen oral immunotherapy?
    Vickery BP
    Immunotherapy; 2015; 7(8):851-3. PubMed ID: 26314347
    [No Abstract]   [Full Text] [Related]  

  • 28. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 30. Allergen extracts for immunotherapy: to mix or not to mix?
    Nony E; Martelet A; Jain K; Moingeon P
    Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen immunotherapy. Review of efficacy and current practice.
    Ohman JL
    Med Clin North Am; 1992 Jul; 76(4):977-91. PubMed ID: 1614242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure.
    Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138
    [No Abstract]   [Full Text] [Related]  

  • 33. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.
    Senti G; Graf N; Haug S; Rüedi N; von Moos S; Sonderegger T; Johansen P; Kündig TM
    J Allergy Clin Immunol; 2009 Nov; 124(5):997-1002. PubMed ID: 19733905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H; Kahlert H
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal duration of allergen immunotherapy.
    Rael E; Lockey RF
    J Allergy Clin Immunol; 2014 Nov; 134(5):1218-9.e2. PubMed ID: 25439231
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel routes for allergen immunotherapy: safety, efficacy and mode of action.
    Moingeon P; Mascarell L
    Immunotherapy; 2012 Feb; 4(2):201-12. PubMed ID: 22339462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy, routes of administration and cytokine networks: an update.
    Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C
    Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.
    Nelson HS
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.